Qiagen N.V. (QGEN)
NYSE: QGEN · IEX Real-Time Price · USD
41.55
-0.23 (-0.55%)
At close: Jul 19, 2024, 4:00 PM
41.81
+0.26 (0.63%)
Pre-market: Jul 22, 2024, 6:52 AM EDT
Qiagen Revenue
Qiagen had revenue of $1.94B in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $458.80M. In the year 2023, Qiagen had annual revenue of $1.97B.
Revenue (ttm)
$1.94B
Revenue Growth
-2.99%
P/S Ratio
4.75
Revenue / Employee
$324,905
Employees
5,967
Market Cap
9.22B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.97B | -176.21M | -8.23% |
Dec 31, 2022 | 2.14B | -110.14M | -4.89% |
Dec 31, 2021 | 2.25B | 381.31M | 20.39% |
Dec 31, 2020 | 1.87B | 343.92M | 22.53% |
Dec 31, 2019 | 1.53B | 24.58M | 1.64% |
Dec 31, 2018 | 1.50B | 84.31M | 5.95% |
Dec 31, 2017 | 1.42B | 79.55M | 5.95% |
Dec 31, 2016 | 1.34B | 57.01M | 4.45% |
Dec 31, 2015 | 1.28B | -63.79M | -4.74% |
Dec 31, 2014 | 1.34B | 42.79M | 3.29% |
Dec 31, 2013 | 1.30B | 47.53M | 3.79% |
Dec 31, 2012 | 1.25B | 84.71M | 7.24% |
Dec 31, 2011 | 1.17B | 82.32M | 7.57% |
Dec 31, 2010 | 1.09B | 77.61M | 7.69% |
Dec 31, 2009 | 1.01B | 116.85M | 13.09% |
Dec 31, 2008 | 892.98M | 243.20M | 37.43% |
Dec 31, 2007 | 649.77M | 184.00M | 39.50% |
Dec 31, 2006 | 465.78M | 67.38M | 16.91% |
Dec 31, 2005 | 398.40M | 17.77M | 4.67% |
Dec 31, 2004 | 380.63M | 29.23M | 8.32% |
Dec 31, 2003 | 351.40M | 52.80M | 17.68% |
Dec 31, 2002 | 298.61M | 34.84M | 13.21% |
Dec 31, 2001 | 263.77M | 46.97M | 21.66% |
Dec 31, 2000 | 216.80M | 58.65M | 37.08% |
Dec 31, 1999 | 158.16M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Walgreens Boots Alliance | 145.53B |
Henry Schein | 12.45B |
Encompass Health | 4.96B |
AptarGroup | 3.54B |
Bruker | 3.00B |
Exact Sciences | 2.53B |
Globus Medical | 1.90B |
QGEN News
- 19 days ago - QIAGEN N.V. to release results for Q2 2024 and hold webcast - GlobeNewsWire
- 24 days ago - QIAGEN welcomes new U.S. guidelines for use of QuantiFERON-TB Gold Plus in detecting tuberculosis infections in children - GlobeNewsWire
- 5 weeks ago - QIAGEN announces 2028 strategy for solid profitable growth - GlobeNewsWire
- 5 weeks ago - QIAGEN's software QCI Interpret accelerates clinical reporting turnaround time for high throughput NGS testing labs - GlobeNewsWire
- 5 weeks ago - QIAGEN publishes 2023 sustainability report, highlighting progress on ESG goals and commitment to sustainable growth - GlobeNewsWire
- 5 weeks ago - QIAGEN launches new QIAcuity digital PCR assays for microbial applications, enhancing infectious disease research and surveillance - GlobeNewsWire
- 6 weeks ago - QIAGEN to discontinue NeuMoDx integrated PCR testing system, support customers during transition period - GlobeNewsWire
- 6 weeks ago - QIAGEN launches digital PCR Assay Design Tool for QIAcuity, expands customization capabilities of its research platform GeneGlobe - GlobeNewsWire